首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers
【24h】

Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers

机译:需要进行有创机械通气的患者,其结果需要接受急诊机械性通气治疗,而这些患者在进行固体化疗时需要进行急性化学疗法

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Acute respiratory failure that requires invasive mechanical ventilation is a leading cause of death in critically ill cancer patients. The aim of this study was to evaluate the outcome and prognostic factors of patients requiring invasive mechanical ventilator for acute respiratory failure, within 1 month of ambulatory chemotherapy for solid cancer. Methods: A retrospective observational study of patients who underwent ambulatory chemotherapy at Samsung Medical Center, between January of 2007 and April of 2009, was employed for this study. Results: A total of 51 patients met the inclusion criteria and were included in the study. The median age was 65 years (25-87) and the majority of the patients were male (n = 38, 74.5 %). There were 42 patients (82.3 %) with lung cancer. The most common cause of acute respiratory failure was pneumonia (n = 24, 47.1 %), followed by acute respiratory failure due to extra-pulmonary infection, drug-induced pneumonitis, alveolar hemorrhage, and cancer progression. The intensive care unit (ICU) mortality was 68.6 % and the most common cause of death in the ICU was uncorrected cause of acute respiratory failure. Before adjustment for others factors, prechemotherapy Eastern Cooperative Oncology Group (ECOG) Performance Scale (PS) (P = 0.03), Sequential Organ Failure Assessment score (P = 0.01), and anemia (P = 0.04) were significantly associated with ICU mortality. However, when adjusted for age, sex, and Acute Physiologic and Chronic Health Evaluation II score, only poor ECOG PS (≥2) was significantly associated with ICU mortality [OR 6.36 (95 % CI (1.02-39.5))]. Conclusions: The outcome of patients with acute respiratory failure needing invasive mechanical ventilation during ambulatory chemotherapy for solid cancer is poor. Prechemotherapy performance status is an independent predictor of mortality.
机译:目的:需要侵入性机械通气的急性呼吸衰竭是重症癌症患者死亡的主要原因。这项研究的目的是评估实体癌的非卧床化疗后1个月内需要使用侵入性机械呼吸机进行急性呼吸衰竭的患者的结局和预后因素。方法:采用回顾性观察性研究方法,对2007年1月至2009年4月在三星医疗中心进行非卧床化疗的患者进行研究。结果:共有51名患者符合纳入标准,并被纳入研究。中位年龄为65岁(25-87岁),大多数患者为男性(n = 38,74.5%)。有42例肺癌患者(占82.3%)。急性呼吸衰竭的最常见原因是肺炎(n = 24,占47.1%),其次是由于肺外感染,药物引起的肺炎,肺泡出血和癌症进展而导致的急性呼吸衰竭。重症监护病房(ICU)的死亡率为68.6%,ICU中最常见的死亡原因是未经纠正的急性呼吸衰竭原因。在调整其他因素之前,化疗前的东部合作肿瘤小组(ECOG)绩效量表(PS)(P = 0.03),器官功能衰竭评估评分(P = 0.01)和贫血(P = 0.04)与ICU死亡率显着相关。但是,如果对年龄,性别以及急性生理和慢性健康评估II评分进行调整,则只有不良ECOG PS(≥2)与ICU死亡率显着相关[OR 6.36(95%CI(1.02-39.5))]。结论:实体癌非卧床化疗期间需要有创机械通气的急性呼吸衰竭患者的预后较差。化疗前的表现状态是死亡率的独立预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号